Company intelligence / Profile preview

Beonchip

Zaragoza, Aragón, Spain

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Beonchip's devices enable advanced in vitro biological experiments, reducing reliance on animal models and expanding capabilities for drug and disease research; clinical drug results are not directly applicable as Beonchip does not conduct drug trials but provides the enabling technology.

Therapeutic areas: GastroenterologyOncologyRheumatologyRare Diseases
Modalities: DeviceMicrofluidic cell culture device
Industry: Non-Drug Biotech

Partnerships

Academic institutions (University of Zaragoza)Horizon EU programsconsortium projects like Moore4Medicalmultiple European university and industry partners

Beyond the preview

Go deeper on Beonchip.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beonchip.

Explore the full profile